Nine pharmaceutical companies have committed to President Trump's drug pricing policies, including lowering U.S. prices for some drugs and participating in the upcoming TrumpRx platform, as part of a broader effort to align U.S. drug prices with those in other developed countries and promote domestic manufacturing. The deals involve offering drugs at most favored nation prices, investing in domestic production, and donating ingredients to the national stockpile, though some drugs are already available as generics.
President Trump announced a deal with Eli Lilly and Novo Nordisk to significantly reduce the prices of popular weight loss drugs for eligible Medicare and Medicaid patients, with plans to launch the TrumpRx program offering these medications at lower costs starting in January, aiming to improve health outcomes and reduce obesity-related risks.
The White House announced a deal to significantly reduce the cost of IVF drugs on the TrumpRx platform, with over 70% discounts for drugs like Gonal-F, Ovidrel, and Cetrotide, and plans to encourage employers to offer more IVF coverage, although it stops short of providing universal free IVF.
The article criticizes the launch of TrumpRx, a new government healthcare website associated with Donald Trump, highlighting its narcissistic branding, disturbing AI-generated images, and questionable claims about lowering drug prices, while also noting potential conflicts of interest involving Trump's family.
AstraZeneca has agreed with the Trump administration to lower drug prices through a deal that includes most-favored-nation pricing for Medicaid and discounts for direct consumer sales, along with expanding manufacturing in the U.S. and receiving tariff exemptions, as part of broader efforts to align U.S. drug prices with those in other developed countries.
President Trump's TrumpRx website promises discounted drugs and new discounts for Medicaid, but experts criticize it as a superficial announcement lacking substantial impact on drug prices for most Americans.
The FDA commissioner praised the Trump administration's plan, TrumpRx, which involves Pfizer offering significant discounts on certain medications through a new government purchasing platform, as a major step toward making prescription drugs more affordable in the US, though experts express skepticism about its overall impact.
President Donald Trump is launching a government-run website called TrumpRx in 2026 to help Americans access lower-priced medications by directing them to discounts on drugmakers’ online stores, primarily for uninsured patients, as part of broader deals with pharmaceutical companies like Pfizer to lower drug prices and boost US manufacturing.
President Trump announced the upcoming launch of 'TrumpRx,' a website aimed at allowing Americans to buy prescription drugs directly at discounted prices, with the site expected to be available in early 2026. This initiative follows Pfizer's agreement to lower drug prices for U.S. consumers and aligns with broader efforts to reduce pharmaceutical costs through new pricing strategies and manufacturing investments.
President Trump announced a deal with Pfizer to lower drug prices for Medicaid and introduce new US drugs at European prices, along with the launch of the TrumpRx website to help consumers buy drugs directly from manufacturers.
President Trump announced a deal with Pfizer to lower drug prices and launched a new website, 'TrumpRx', as part of efforts to reduce U.S. drug costs by linking them to lower prices paid abroad.
Donald Trump announced the launch of 'TrumpRx,' a government website allowing Americans to buy prescription drugs directly at potentially lower prices, with Pfizer's involvement and an agreement to sell drugs to Medicaid at reduced rates.
President Trump is set to announce the launch of 'TrumpRx', a website for discounted drugs, and a deal with Pfizer to lower medication costs, amid ongoing efforts to reduce drug prices in the US through policies like the 'Most Favored Nation' rule and direct-to-consumer sales channels, despite industry opposition and legal challenges.
Pfizer has agreed to lower prices on some prescription drugs for all Americans and Medicaid, with discounts up to 50-100%, as part of the Trump administration's efforts to reduce drug costs through the 'most favored nation' policy, and plans to launch a government-operated website 'TrumpRX' for online drug purchases.
President Trump announced a deal with Pfizer to lower drug prices for Medicaid and introduce a new 'TrumpRx' website for direct-to-consumer sales, with discounts averaging 50-85%, as part of broader efforts to reduce U.S. drug costs, though experts question the overall impact on consumers.
